December 2020 Newsletter
Laboratory Aspects of Establishing a Fertility Preservation Service
Dr. Debra Gook
Head of Cryopreservation Services
Royal Women’s Hospital, Melbourne, Australia
April 2020 Newsletter
Summary of the ISFP congress, New York, 14–16 November, 2019
Dolmans Marie-Madeleine & Hossay Camille & Cacciottola Luciana & Schattman Glenn
September 2019 Newsletter No.2
Do we need a different nomenclature for ‘oncofertility’?
Newletter by Dr. Claus Yding Andersen
Laboratory of Reproductive Biology, University Hospital of Copenhagen, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
September 2019 Newsletter
Could AMH treatment have a role in fertility preservation?
Paper Review by Dr. Roger Gosden
Journal of Assisted Reproduction and Genetics (2019) 36:1793–1803
Hadassa Roness et al.
July 2019 Newsletter
Fertility preservation in patients with Borderline Ovarian Tumors
Rossella Masciangelo M.D. PhD
January 2019 Newsletter
Anti-Müllerian hormone (AMH) and its multiple purposes in fertility preservation
Laura Detti, MD
July 2018 Newsletter
Fertility preservation in young Leukemia patients
Dr. Shapira Moran, Dr. Ra'anani Hila, Mrs. Sanaz Derech Chaim, Prof. Dror Meirow
June 2017 Newsletter - part 1
Fertility preservation for women with breast cancer
Kenny A. Rodriguez-Wallberg MD, PhD
June 2017 Newsletter - part 2
Oncofertility - the Oncologist point of view
Giovanni Codacci-Pisanelli MD, PhD
FERTILITY PRESERVATION SOCIETY (India)
Summary of the 3rd Annual Conference of the Fertility Preservation
Society of India - Fertiprotect, August 2016, Bengaluru, India.
October 2015 Newsletter
Fertility Consideration in BRCA Mutation Carriers
Dr. Peer Gil, Shapira Moran, Dr. Ra'anani Hila
August 2015 Newsletter
Young Scientist Congress in Brussels & Update on Fertility Preservation For Girls and Young Women With Cancer
Professor Hamish Wallace
January 2014 Newsletter
Possible malignant cell contamination in transplanted ovarian tissue Professor Claus Yding Andersen
Transplantation of ovarian tissue in cured cancer patients: is there a risk? Dolmans Marie-Madeleine, MD, PhD.